Rhythm Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
222 Berkeley St Fl 12, Boston, Massachus...Phone Number
(857) 264-4280Website
www.rhythmtx.comRevenue
$217.2 MillionStock Symbol
RYTMIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
4
1
1
1
1
About Rhythm Pharmaceuticals
Rhythm Pharmaceuticals is a biopharmaceutical research and development company focused on developing precision medicines for rare genetic obesity disorders. The company specializes in treatments targeting the melanocortin-4 receptor pathway diseases that cause hyperphagia and severe obesity. Founded in 2008, Rhythm Pharmaceuticals conducts scientific research to address the root causes of these rare conditions, advancing therapeutic solutions for patients with these specific genetic disorders. The company operates internationally with presence in North America and Europe, including France and the Netherlands.Explore more
Rhythm Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
AH
Senior Director, Organizational Effectiveness...
MW
People Operations Senior Director, Total Rewa...
TS
Senior Director, Human Resources & Business P...
TM
Director, Field Development
HT
Director, Human Resources, International (Jap...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rhythm Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Rhythm Pharmaceuticals launches new products
Check out if Rhythm Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Rhythm Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if Rhythm Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Rhythm Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Rhythm Pharmaceuticals has new funding data
Rhythm Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Rhythm Pharmaceuticals
Recommended Actions
Reach out to Masked Content who joined Rhythm Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to Rhythm Pharmaceuticals
Compare insights from companies similar to Rhythm Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$23.9M
51-200
Private
$126.7M
2001
SB
Sofia BlehautAssociate Director and Regional Clinical Operations Manager
Company Profile Activity
Activity Insights
Rhythm Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rhythm Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals financials insights
Gather financial insights about Rhythm Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Series A
$40M
2012
Series B
$33M
2017
Other Financing Round
$41M
Stock Offering
$138M
2018
Stock Offering
$174M
2019
Stock Offering
$172.5M
2022
Debt
$100M
2024
Series A
$150M
Rhythm Pharmaceuticals Tech Stack
A closer look at the technologies used by Rhythm Pharmaceuticals
Most Recent Scoops
Hiring Plans
Rhythm Pharmaceuticals has more open roles in Marketing than it has had at any time in the past 6 months.
Hiring Plans
Hiring Plans
Rhythm Pharmaceuticals has more open roles in Sales than it has had at any time in the past 6 months. Areas of expertise include: Pharmaceutical Sales.
Hiring Plans
Hiring Plans
Rhythm Pharmaceuticals has more open roles in Finance than it has had at any time in the past 6 months. Areas of expertise include: Process Design, Cash Flow Forecasting, Project Management, Scenario Analysis, Banking Administration, Data Manipulation, and Financial Integration.
Hiring Plans
Open Position
Open Position
Rhythm Pharmaceuticals News & Media
Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the publication of a new, evidence-based consensus-driven diagnostic algorithm for Bardet-Biedl syndrome (BBS). “Streamlining Diagnosis of Bardet-Biedl Syndrome: New Diagnostic Algorithm with Updated Criteria,” was published in the peer-reviewed American JouRhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
BOSTON, May 26, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David Meeker, M.D., Chairman, President and Chief Executive Officer, and Hunter Smith, Chief Financial Officer, will participate in fireside chats at two upcoming conferences.Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Rhythm Pharmaceuticals, Inc. (RYTM) Bank of America Global Healthcare Conference 2026 May 13, 2026 6:00 PM EDTCompany ParticipantsDavid Meeker - Chairman,...Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology
– Real world data showed clinically meaningful BMI reductions with setmelanotide in 62 adults with 12-month data living with acquired hypothalamic obesity (HO) in France –
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Rhythm Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Rhythm Pharmaceuticals is a biopharmaceutical research and development company focused on developing precision medicines for rare genetic obesity disorders. The company specializes in treatments targeting the melanocortin-4 receptor pathway diseases that cause hyperphagia and severe obesity. Founded in 2008, Rhythm Pharmaceuticals conducts scientif... Read More
